Par Pharmaceutical Companies Inc.’s (PRX) MACD indicator has moved into bullish territory with a reading of 0.0249. The Zacks #2 Rank (“Buy”) stock increased slightly to $27.21 in afternoon trade. The Zacks Consensus Estimate on the company’s earnings for 2010 moved up 11 cents over the past month to $2.43 per share.
 
PAR PHARMA COS (PRX): Free Stock Analysis Report
 
Zacks Investment Research